EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antiviral resistance and barrier integrity at the maternal-fetal interface restrict hepatitis E virus from crossing the placental barrier

Debin Tian iD, Wen Li iD, C Lynn Heffron, Hassan M Mahsoub iD, Bo Wang iD, Tanya LeRoith iD, Xiang-Jin Meng iD

Proceedings of the National Academy of Sciences · 06.05.2025 · 122 (18)

DOI: 10.1073/pnas.2501128122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025-05. Verfasst von Debin Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State Univer…. Hauptthemen laut MEDLINE: Hepatitis E virus, Hepatitis E, Placenta, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis E virus (HEV) genotype 1 (HEV-1) infection in pregnant women is associated with adverse outcomes of pregnancy including fulminant hepatic failure, fetal loss, premature birth, and neonatal mortality, although the underlying mechanisms remain largely unclear. In this study, we first demonstrated that HEV-1 robustly infects pregnant gerbils and causes pregnancy-associated adverse outcomes, which were recorded in 4/6 HEV-1-infected but only 1/5 in PBS-inoculated pregnant gerbils. However, vertical transmission of HEV-1 from mothers to newborns is not evident, as HEV-1 RNA was not detected in uterus tissues or in newborn pups. To further determine whether HEV-1 can cross the placental barrier, we established an in vitro blood–placental barrier by coculturing human placental trophoblast cells (BeWo) and umbilical vein endothelial cells (HUVEC) in Transwell inserts. By using the placental barrier under the conditions in this study, we showed that quasi-enveloped or nonenveloped HEV-1, HEV-3, or HEV-4 virions do not readily cross the barrier prior to 4 d postinoculation when it has high barrier integrity. Importantly, we demonstrated that the placental barrier induces local antiviral resistance at the maternal-fetal interface, that interactions between maternal- and fetal-derived cocultured cells are important for induction of antiviral resistance, and that anti-HEV resistance can be transferred to nonplacental HepG2 liver cells. We also revealed that the main effectors of antiviral resistance at the placental barrier are type III interferons (IFN-λ1, λ2/3) and the chemokine CXCL10. The findings have important implications in understanding the mechanisms leading to HEV-1-associated maternal and fetal adverse outcomes in pregnant women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis E virusHepatitis EPlacentaPregnancy Complications, InfectiousMaternal-Fetal ExchangeFemalePregnancyAnimalsHumansInfectious Disease Transmission, VerticalHuman Umbilical Vein Endothelial CellsTrophoblastsAntiviral Agents

Stichwörter der Autor:innen

antiviral resistanceblood–placental barrierhepatitis E viruspregnant womenvertical transmission

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061.
  • Center for Emerging, Zoonotic and Arthropod-Borne Pathogens, Fralin Life Sciences Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061.

ORCID-Profile: Debin Tian, Wen Li, Hassan M Mahsoub, Bo Wang, Tanya LeRoith, Xiang-Jin Meng

Förderung

  • NIAID NIH HHS

Zitieren

APA

Tian, D., Li, W., Heffron, C. L., Mahsoub, H. M., Wang, B., LeRoith, T., & Meng, X. J. (2025). Antiviral resistance and barrier integrity at the maternal-fetal interface restrict hepatitis E virus from crossing the placental barrier. Proceedings of the National Academy of Sciences, 122(18). https://doi.org/10.1073/pnas.2501128122

Vancouver

Tian D, Li W, Heffron CL, Mahsoub HM, Wang B, LeRoith T, et al. Antiviral resistance and barrier integrity at the maternal-fetal interface restrict hepatitis E virus from crossing the placental barrier. Proceedings of the National Academy of Sciences. 2025;122(18). doi:10.1073/pnas.2501128122

BibTeX
@article{Tian2025,
  author = {Tian, Debin and Li, Wen and Heffron, C Lynn and Mahsoub, Hassan M and Wang, Bo and LeRoith, Tanya and Meng, Xiang-Jin},
  title = {Antiviral resistance and barrier integrity at the maternal-fetal interface restrict hepatitis E virus from crossing the placental barrier},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {18},
  doi = {10.1073/pnas.2501128122}
}
Kostenlos starten →